HK-listed Giant Biogene falls on discounted share sale
17/04/2025 02:59
** Giant Biogene 2367.HK slips 9.7% to HK$66.5; on course for biggest one-day pct decline since April 7 ** Stock hits the lowest since April 9 ** Chinese beauty and health products developer raises HK$2.33 bln ($301 mln) in a HK top up placement, according to a term sheet seen by Reuters ** Sells 35 mln shares at HK$66.65, a 9.5% discount to Wednesday's close ** Stock up 38.4% YTD ($1 = HK$7.7609) (Reporting by Donny Kwok) ((donny.kwok@thomsonreuters.com))
Recent news on Giant Biogene Holding
See all newsGiant Biogene's profit drops on higher distribution expenses
Brief: Giant Biogene Says Cross-Linked Recombinant Collagen Implant Receives China Medical Device Registration Certificate
Brief: Giant Biogene To Distribute Final Dividends Of Rmb0.5390 Per Share
Brief: Giant Biogene's Unit Received NMPA Medical Device Registration Certificate For Recombinant Collagen, Sodium Hyaluronate Solution
HK-listed Giant Biogene jumps on share buyback plan